<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04866433</url>
  </required_header>
  <id_info>
    <org_study_id>2101-185-1193</org_study_id>
    <nct_id>NCT04866433</nct_id>
  </id_info>
  <brief_title>The Effect of Real-time Binaural Sound on Sedation Using Dexmedetomidine</brief_title>
  <official_title>The Effect of Real-time Binaural Sound on Sedation Using Dexmedetomidine During Spinal Anesthesia: a Randomized, Placebo-controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Seoul National University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Seoul National University Hospital</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of the study is to evaluate whether real-time binaural sound affects the dose of&#xD;
      dexmedetomidine in patients undergoing sedation with dexmedetomidine after spinal anesthesia.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Patients undergoing sedation with dexmedetomidine after spinal anesthesia are randomly&#xD;
      assigned to binaural group, audio group, and control group. After spinal anesthesia, SedLine&#xD;
      continuous monitoring is started. Real-time binaural sound applied music is played to the&#xD;
      binaural group, normal music is played to the audio group, and headphones with no sound are&#xD;
      applied to the control group. Observer's Assessment of Alertness/Sedation Scale (OAAS) and&#xD;
      Patient State Index (PSi) are checked every minute after loading of dexmedetomidine at the&#xD;
      rate of 1 μg/kg for 10 minutes (6 μg/kg/hr). Loading is stopped when the OAAS score is 3 or&#xD;
      less. Then, dexmedetomidine is continuously infused at a rate of 0.6 μg/kg/hr, and OAAS is&#xD;
      evaluated every 30 minutes. The infusion rate is lowered (-0.1 μg/kg/hr) if OAAS is lower&#xD;
      than 3, and increased (+0.1 μg/kg/hr) if OAAS is higher than 3. The continuous infusion rate&#xD;
      should not exceed 1 μg/kg/hr. The total dexmedetomidine dose corrected by the patient's&#xD;
      predicted body weight and infusion time (μg/kg/hr) was compared between groups. In addition,&#xD;
      the loading dose (μg/kg) and continuous infusion dose (μg/kg/hr), additional sedative use,&#xD;
      blood pressure, heart rate, ECG changes, respiratory depression, and oxygen saturation were&#xD;
      observed. The patient's satisfaction is evaluated after the surgery.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">June 1, 2021</start_date>
  <completion_date type="Anticipated">May 1, 2022</completion_date>
  <primary_completion_date type="Anticipated">April 28, 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Dexmedetomidine dose</measure>
    <time_frame>Intraoperative (During sedation for surgery)</time_frame>
    <description>Total dexmedetomidine dose corrected by patient's predicted body weight and infusion time (μg/kg/hr)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Observer's Assessment of Alertness/Sedation Scale (0~5)</measure>
    <time_frame>During sedation for surgery and at post anesthesia care unit (PACU)</time_frame>
    <description>Observer's Assessment of Alertness/Sedation Scale (0, does not respond to painful trapezius squeeze; 1, responds only after painful trapezius squeeze; 2, responds only after mild prodding or shaking; 3, responds only after name is called loudly, repeatedly, or both; 4, responds lethargically to name spoken in normal tone; 5, responds readily to name spoken in normal tone)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Patient State Index (PSi)</measure>
    <time_frame>Intraoperative (During sedation for surgery)</time_frame>
    <description>Patient State Index (PSi) acquired through the Sedline Sedation monitor (Sedline, Massimo, USA)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Dexmedetomidine loading dose</measure>
    <time_frame>Intraoperative (During sedation for surgery)</time_frame>
    <description>Dexmedetomidine loading dose injected until OAAS reaches 3 or less</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Dexmedetomidine continuous infusion dose</measure>
    <time_frame>Intraoperative (During sedation for surgery)</time_frame>
    <description>Total amount of dexmedetomidine infused from the end of dexmedetomidine loading to the start of suturing the surgical site</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Additional sedatives</measure>
    <time_frame>Intraoperative (During sedation for surgery)</time_frame>
    <description>Use of additional sedatives</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Adverse event</measure>
    <time_frame>Intraoperative (During sedation for surgery)</time_frame>
    <description>Incidence of hypotension, hypertension, bradycardia, ECG change, need of vasopressors, respiratory suppression, desaturation</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Patient satisfaction</measure>
    <time_frame>Intraoperative (At the time of leaving the operating room)</time_frame>
    <description>Patient's satisfaction with intraoperative sedation Score from 0 to 10) with intraoperative sedation measured at the time of leaving the operating room (0~10)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Postanesthesia recovery score (0~10)</measure>
    <time_frame>At the postanesthesia recovery room</time_frame>
    <description>Postanesthesia recovery score (0~10, higher scores mean better recovery)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Postoperative delirium</measure>
    <time_frame>From the end of the surgery to the hospital discharge, an average of 1 week</time_frame>
    <description>Incidence of postoperative delirium</description>
  </secondary_outcome>
  <other_outcome>
    <measure>EEG power in delta band</measure>
    <time_frame>During sedation for surgery</time_frame>
    <description>EEG power in delta band (0.3~4Hz) acquired through the Sedline Sedation monitor (Sedline, Massimo, USA)</description>
  </other_outcome>
  <other_outcome>
    <measure>EEG power in theta band</measure>
    <time_frame>During sedation for surgery</time_frame>
    <description>EEG power in theta band (4~8Hz) acquired through the Sedline Sedation monitor (Sedline, Massimo, USA)</description>
  </other_outcome>
  <other_outcome>
    <measure>EEG power in alpha band</measure>
    <time_frame>During sedation for surgery</time_frame>
    <description>EEG power in alpha band (8~13Hz) acquired through the Sedline Sedation monitor (Sedline, Massimo, USA)</description>
  </other_outcome>
  <other_outcome>
    <measure>EEG power in beta band</measure>
    <time_frame>During sedation for surgery</time_frame>
    <description>EEG power in beta band (13~30Hz) acquired through the Sedline Sedation monitor (Sedline, Massimo, USA)</description>
  </other_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">189</enrollment>
  <condition>Sedative Adverse Reaction</condition>
  <arm_group>
    <arm_group_label>Binaural group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Play realtime binaural sound applied music through headphones</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Audio group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Play music through headphones.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control group</arm_group_label>
    <arm_group_type>Sham Comparator</arm_group_type>
    <description>Wear headphones that do not produce sound.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Real-time binaural sound</intervention_name>
    <description>Play music with a frequency difference (real-time binaural sound) in each ear through headphones during sedation.</description>
    <arm_group_label>Binaural group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Music</intervention_name>
    <description>Play the same music in both ears through headphones during sedation</description>
    <arm_group_label>Audio group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Control</intervention_name>
    <description>Just wear headphones during sedation</description>
    <arm_group_label>Control group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Adult patients undergoing sedation with dexmedetomidine during spinal anesthesia for&#xD;
             surgery with an estimated time of 90 minutes or longer&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  ASA physical status classification 3-4&#xD;
&#xD;
          -  Patients with hearing loss or using hearing aids&#xD;
&#xD;
          -  Patients who received narcotic analgesics or sedative drugs within 1 week&#xD;
&#xD;
          -  Patients with alcohol dependence or drug dependence&#xD;
&#xD;
          -  Patients with drug hypersensitivity to dexmedetomidine&#xD;
&#xD;
          -  Patients with arrhythmia, cardiovascular disease, decreased cardiac function and&#xD;
             decreased cardiac output&#xD;
&#xD;
          -  Patients who are judged to be difficult to use sedative drugs due to severe&#xD;
             respiratory disease&#xD;
&#xD;
          -  Patients with liver failure&#xD;
&#xD;
          -  Patients with kidney failure or on dialysis&#xD;
&#xD;
          -  Patients judged to be unsuitable for the clinical trial by the researchers&#xD;
&#xD;
          -  Patients whose actual operation time is less than 30 minutes&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>19 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Hee-Soo Kim, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Seoul National University Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Hee-Soo Kim, M.D. PhD</last_name>
    <phone>+82-02-2072-3664</phone>
    <email>dami0605@snu.ac.kr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Jinyoung Bae, M.D.</last_name>
    <email>baejy88@gmail.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Seoul National University Hospital</name>
      <address>
        <city>Seoul</city>
        <zip>03080</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Hee-Soo Kim, Phd</last_name>
      <phone>+82220723659</phone>
      <email>dami0605@snu.ac.kr</email>
    </contact>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <verification_date>April 2021</verification_date>
  <study_first_submitted>April 19, 2021</study_first_submitted>
  <study_first_submitted_qc>April 26, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">April 29, 2021</study_first_posted>
  <last_update_submitted>July 23, 2021</last_update_submitted>
  <last_update_submitted_qc>July 23, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">July 26, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Seoul National University Hospital</investigator_affiliation>
    <investigator_full_name>Hee-Soo Kim</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

